» Authors » Asada Leelahavanichkul

Asada Leelahavanichkul

Explore the profile of Asada Leelahavanichkul including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 223
Citations 5095
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sae-Khow K, Charoensappakit A, Udompornpitak K, Saisorn W, Issara-Amphorn J, Palaga T, et al.
Cell Death Discov . 2025 Feb; 11(1):63. PMID: 39962056
Spleen tyrosine kinase (Syk), an important hub of immune signaling, is activated by several signalings in active lupus which could be interfered by Syk inhibitor but is still not completely...
2.
Shan A, Hlaing K, Leelahavanichkul A, Amornphimoltham P
Eur J Oral Sci . 2025 Jan; 133(1):e13034. PMID: 39780329
Despite treatment advances, head and neck squamous cell carcinoma (HNSCC) still poses a significant global health challenge. Combination therapies have emerged as more effective strategies than traditional chemotherapy in clinical...
3.
Cheibchalard T, Leelahavanichkul A, Chatthanathon P, Klankeo P, Hirankarn N, Somboonna N
PLoS One . 2024 Dec; 19(12):e0314662. PMID: 39637140
The gut mycobiota (fungal microbiota) plays a crucial role in the immune system, potentially impacting autoimmune diseases such as systemic lupus erythematosus (SLE). Despite growing interest, data on intestinal fungi...
4.
Phuengmaung P, Chongrak C, Saisorn W, Makjaroen J, Singkham-In U, Leelahavanichkul A
Int J Mol Sci . 2024 Nov; 25(22). PMID: 39596223
Due to the possible coexistence of (KP) and (CA), strains of KP and CA with biofilm production properties clinically isolated from patients were tested. The production of biofilms from the...
5.
Chatthanathon P, Leelahavanichkul A, Cheibchalard T, Wilantho A, Hirankarn N, Somboonna N
Sci Rep . 2024 Nov; 14(1):29391. PMID: 39592752
No abstract available.
6.
Sithu Shein A, Wannigama D, Hurst C, Monk P, Amarasiri M, Wongsurawat T, et al.
Sci Rep . 2024 Nov; 14(1):28992. PMID: 39578508
The increasing occurrence of hospital-associated infections, particularly bacteremia, caused by extensively drug-resistant (XDR) carbapenemase-producing colistin-resistant Klebsiella pneumoniae highlights a critical requirement to discover new therapeutic alternatives. Bacteriophages having host-specific bacteriolytic...
7.
Panpetch W, Tumwasorn S, Leelahavanichkul A
PLoS One . 2024 Nov; 19(11):e0309106. PMID: 39546435
The impact of Pseudomonas aeruginosa (PA) was explored in a mouse model with non-diarrheal gut permeability defect using 1.5% dextran sulfate solution (DSS) plus antibiotics (ATB) with or without orally...
8.
Chienwichai K, Phirom S, Wuttiputhanun T, Leelahavanichkul A, Townamchai N, Avihingsanon Y, et al.
Syst Rev . 2024 Nov; 13(1):278. PMID: 39533400
Background: The effects of various risk and associated factors on post-kidney transplant anemia (PTA) have not been fully compared and estimated. This meta-analysis aims to elucidate factors contributing to PTA...
9.
Haque M, Benjaskulluecha S, Boonmee A, Kongkavitoon P, Wongprom B, Pattarakankul T, et al.
Sci Rep . 2024 Nov; 14(1):27492. PMID: 39528715
O-methylguanine-DNA methyltransferase (MGMT) is a DNA damage repair enzyme. The roles of this enzyme in immune cells remain unclear. In this study, we explored the roles of MGMT in bone...
10.
Sithu Shein A, Wannigama D, Hurst C, Monk P, Amarasiri M, Badavath V, et al.
Biomed Pharmacother . 2024 Nov; 168:115793. PMID: 39491417
Given the rise of multidrug-resistant (MDR) Pseudomonas aeruginosa infections, alternative treatments are needed. Anti-pseudomonal phage therapy shows promise, but its clinical application is limited due to the development of resistance...